Editorial: Leishmaniasis and immunity: challenges, advances and future perspective.
作者信息
Ejazi Sarfaraz Ahmad, Satoskar Abhay, Singh Neetu
机构信息
Fischell Department of Bioengineering, A. James Clark School of Engineering, University of Maryland, College Park, MD, United States.
The Ohio State University, Columbus, OH, United States.
出版信息
Front Immunol. 2025 Aug 6;16:1666020. doi: 10.3389/fimmu.2025.1666020. eCollection 2025.
Abstract
摘要
相似文献
1
Editorial: Leishmaniasis and immunity: challenges, advances and future perspective.
Front Immunol. 2025 Aug 6;16:1666020. doi: 10.3389/fimmu.2025.1666020. eCollection 2025.
2
An Insight Into Systemic Immune Response in Mediated Atypical Cutaneous Leishmaniasis in the New Endemic State of Himachal Pradesh, India.
Front Immunol. 2022 Jan 4;12:765684. doi: 10.3389/fimmu.2021.765684. eCollection 2021.
3
Chemokines in host-parasite interactions in leishmaniasis.
Trends Parasitol. 2006 Jan;22(1):32-40. doi: 10.1016/j.pt.2005.11.010. Epub 2005 Nov 23.
4
A comprehensive phenotypic and genotypic taxonomic review of Leishmania (Leishmania) poncei n. sp. (Kinetoplastea: Trypanosomatidae): a novel agent of cutaneous (non-ulcerated) and visceral leishmaniasis in Honduras, Central America.
Trop Dis Travel Med Vaccines. 2025 Jul 28;11(1):27. doi: 10.1186/s40794-025-00264-1.
5
IL-12 and IFN-γ in Response to Leishmania Infantum Antigens in Felines From an Endemic Area for Visceral Leishmaniasis.
Parasite Immunol. 2025 Aug;47(8):e70021. doi: 10.1111/pim.70021.
6
Understanding the immune responses involved in mediating protection or immunopathology during leishmaniasis.
Biochem Soc Trans. 2021 Feb 26;49(1):297-311. doi: 10.1042/BST20200606.
7
[Defining the Molecular Signal Pathways and Upstream Regulators in Cutaneous Leishmaniasis with Transcriptomic Data Approach].
Mikrobiyol Bul. 2021 Jan;55(1):67-80. doi: 10.5578/mb.20092.
8
Phenotypical and genotypical differences among Leishmania (Leishmania) amazonensis isolates that caused different clinical frames in humans and dogs: A systematic review.
Acta Trop. 2021 Sep;221:106018. doi: 10.1016/j.actatropica.2021.106018. Epub 2021 Jun 19.
9
Imaging host-Leishmania interactions: significance in visceral leishmaniasis.
Parasite Immunol. 2013 Sep-Oct;35(9-10):256-66. doi: 10.1111/pim.12044.
10
Association of HLA class I and II genes with cutaneous leishmaniasis: a case control study from Sri Lanka and a systematic review.
BMC Infect Dis. 2016 Jun 14;16:292. doi: 10.1186/s12879-016-1626-8.
本文引用的文献
1
Cutaneous Leishmaniasis in the Context of Global Travel, Migration, Refugee Populations, and Humanitarian Crises.
Clin Pract. 2025 Apr 8;15(4):77. doi: 10.3390/clinpract15040077.
2
Anti-leishmanial therapies: overcoming current challenges with emerging therapies.
Expert Rev Anti Infect Ther. 2025 Feb-Apr;23(2-4):159-180. doi: 10.1080/14787210.2024.2438627. Epub 2025 Mar 24.
3
Vaccine Designing Technology against Leishmaniasis: Current Challenges and Implication.
Curr Drug Discov Technol. 2025;22(2):e240524230315. doi: 10.2174/0115701638291767240513113400.
4
The pathogenicity and virulence of Leishmania - interplay of virulence factors with host defenses.
Virulence. 2022 Dec;13(1):903-935. doi: 10.1080/21505594.2022.2074130.
5
Understanding the immune responses involved in mediating protection or immunopathology during leishmaniasis.
Biochem Soc Trans. 2021 Feb 26;49(1):297-311. doi: 10.1042/BST20200606.
6
Developments in diagnosis and treatment of visceral leishmaniasis during the last decade and future prospects.
Expert Rev Anti Infect Ther. 2013 Jan;11(1):79-98. doi: 10.1586/eri.12.148.
Zotero 插件